Yoga Based Psychotherapy Group Feasibility and Efficacy Study

NCT ID: NCT01524172

Last Updated: 2018-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2017-08-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This preliminary study will examine the feasibility of conducting a randomized clinical trial of Yoga Based Psychotherapy (YBPG) and standard care mental health (SCMH) treatment compared to SCMH for children ages 8-12 years who have a history of neglect and maltreatment (trauma). The goal of the study is to inform the method and sample size for a larger randomized trial to study the effect of YMBT with SCMH compared to SCMH in improving child regulation of behavior, emotions, and daily functioning. Children who have experienced trauma, including sexual abuse, physical abuse, emotional abuse, exposure to community or domestic violence, parental substance abuse, mental health disorders, and incarceration are at risk to have dysregulation of mood, emotions and behavior. In addition, children exposed to neglect and trauma may have poor attachment to caregivers and poor peer relations. It is hypothesized the using YBPG as an adjunct to SCMH may improve children's regulation of emotion and behavior.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

One hundred fifty children (ages 8-12 years) treated at the Center for Child and Family Traumatic Stress (CCTFS) for at least 3 months and their caregivers (total n=300 individuals) will be eligible to be enrolled in this randomized preliminary study if CCTFS Clinician identifies that the child is continuing to have difficulty with behavior and emotional regulation. Children will be invited to participate in the study. Informed consent will be obtained following explanation of the study. If the child meets both Stage 1 and 2 Screening criteria,

Stage 1 Screening:

Child receives a T-score \> 60 on any of the Child Behavior Checklist Parent Rating Scales, and

Stage 2 Screening:

KKFC Psychiatric evaluation (Child Psychiatrist will be masked to study status). Child Psychiatrist evaluation will determine whether medication is appropriate for the child and whether the child/family environment is stable and safe. If the child is deemed appropriate for psychotropic medications, other than stimulants, the child will not be eligible for the study (due to the possible changes in one of the outcome measures, heart rate variability, that will likely result from use of psychotropic medications that can not be stopped 24 hours prior to study evaluation). \[Children on stimulant medication will be asked to stop medication one day prior to study evaluation and of the day of evaluation.\]

The child will be randomized to Group 1: to continue Standard Care Mental Health (SCMH) treatment or Group 2: Standard Mental Health and Yoga Based Psychotherapy Group.

Children with T-scores lower than 60 will continue in Standard Mental Health Treatment. Recruitment will take place over three years.

A block randomization design (block size 4) will be used to ensure roughly equal distribution of YBPG and SCMH patients over the enrollment time. An opaque bag with four colored marbles (two red, two black) will be utilized for the randomization. The child, in the presence of the parent, will be asked to select a colored marble out of the bag; the marbles will be replaced after enrollment of sets of 4 children. Depending on the color of the marble the child will be assigned to either YBPG or SCMH.

Children randomized to YBPG must be cleared by their pediatric care provider (Appendix 1). Children in YBPG group will participate in YBPG as outlined in Appendix 2; participation duration is expected to be 12 weeks. Parents in the YBPG group will participate in a psychoeducational intervention to learn about YBPG and support the child's practice of YBPG. Following 12 weeks of YBPG children will resume SCMH if necessary.

Children will be assessed following informed consent, at 3 months (following YBPG or 6 months of SCMH), 6 months, and 12 months following randomization.

Assessments:

1. Baseline EKG and respiratory rate (RR) will be measured for 5 minutes. Heart rate variability will be measured using a data collection system that will take EKG and respiratory rate recordings for 5 minutes, and analyzed using the CardioBatch software from the Brain Body Center of the University of Illinois. The Trier Social Stress Test 13 for children will be administered. The Trier consists of the research assistant telling the child the beginning of a story and having the child complete the story in 5 minutes. Then the child is asked to perform math problems for 5 minutes. EKG and respiratory rate (RR) will be re-measured for 10 minutes after the Trier.
2. Child Behavior Checklist (CBCL) 14;15. The CBCL is a written measure designed to assess behavioral and emotional problems in children. There are several forms including a version for children from 1 1/2 to 5 years and a version for children 6-18 years 14;15. There are also Parent, Youth, and Teacher rating forms. The Youth Behavior Rating will be used to obtain a self-report of the child's behavioral and emotional status. Each version yields standard scores (Mean = 50, standard deviation = 10) to assess behavior problems in several specific areas; these scores are also combined into three global scores: an Internalizing score for emotional problems, an Externalizing score for behavior problems, and a Total problem score. The Parent Questionnaire form of the CBCL will be used. The CBCL is expected to take 20 minutes to complete.
3. Trauma Symptom Checklist for Young Children (TSCYC) and Trauma Symptom Checklist for Children (TSCC) 16: The TSCYC is a 90-item parent report of children's symptoms associated with traumatic events (e.g., child abuse, peer assaults, community violence). The TSCYC is normed and standardized as a trauma measure for children ages three to 12 years and includes measurements of validity of parent report and norms for the number of waking hours the parent spends with the child during an average week. The instrument includes nine subscales, Post-traumatic Stress-Intrusion, Post-traumatic Stress-Avoidance, Post-traumatic Stress-Arousal, Post-traumatic Stress-Total, Sexual Concerns, Dissociation, Anxiety, Depression, and Anger/Aggression. The TSCYC is expected to take 15-20 minutes to complete. Alpha values on a multi-site clinical sample of traumatized children ranged from 0.81 for Sexual Concerns to 0.93 for Post-traumatic Stress-Total17. The TSCC is a 54 item child questionnaire that has Anxiety, Depression, Anger, Posttraumatic Stress, Dissociation, and Sexual Concerns. Alpha values range from 0.77 for Sexual Concerns to 0.89 for Anger. The TSCC is expected to take 10-15 minutes to complete.
4. Behavior Emotional Rating Scale (BERS-2) 18: The BERS-2 is a 52-item Likert scale that measures the children emotional and behaviors strengths through parent, child, and observer report. The BERS-2 is designed for children ages 5 years to 18 years and is divided into five subscales, namely, (1) Interpersonal Strengths, (2) Family Involvement, (3) Intrapersonal Strengths, (4) School Functioning, and (5) Affective Strengths. Teacher/Clinician, Parent, and Youth Rating Scales will be used in this grant to assess child behavioral and emotional functioning. Cultural/ethnic normative sample were representative of the United States population. Internal consistency ranges from 0.77 to 0.99. The BERS is expected to take 15 minutes to complete.
5. The University of California Los Angeles-Post Traumatic Stress Disorder (UCLA-PTSD) is used to screen both for exposure to traumatic events and for DSM-IV PTSD symptoms in children and adolescents who report traumatic experiences. The UCLA PTSD is expected to take approximately 15 minutes.
6. The Ontario Child Neglect Index (CNI) is a clinician administered assessment designed to identify types and severity of different forms of child neglect. It is designed for use with families already identified by a child protective service agency. The CNI is a 6-scale index and utilizes a 4- to 5-level rating of severity (e.g., adequate, inconsistent, inadequate, seriously inadequate). The score is interpreted as a severity rating of neglect, rather than a binary (yes/no) neglect score. Scores can range from 0-80. The recommended cutoff score is 50. The CNI is expected to take approximately 5 minutes to complete.
7. Demographic information (e.g, gender, age, race/ethnicity, parental age, education, employment, marital status, etc.) will be collected. In addition, medical information including medications, psychiatric diagnosis, birth history, history of maltreatment and psychosocial history will be obtained by parent interview or electronic record review.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emotional Lability PTSD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Mental Health Treatment

Trauma-informed evidence supported mental health treatment

Group Type ACTIVE_COMPARATOR

Standard Mental Health Treatment

Intervention Type BEHAVIORAL

Trauma and evidence informed therapy

Yoga Based Psychotherapy Group

Yoga Based Psychotherapy will be used as an adjunct mental health interventions

Group Type EXPERIMENTAL

Yoga Based Psychotherapy Group

Intervention Type BEHAVIORAL

YBPG promotes self-regulation (attention span and physical and verbal expression/outbursts); self-soothing (breathing and movement techniques that physiologically calm when the child encounters stress or reminders of trauma); competency (successful social interaction, appropriate expression of needs and feelings, healthy coping with stress or crisis); self-awareness (of thoughts and feelings by first increasing awareness of the body and its sensations through yoga); self-esteem (positive self-regard, increase accomplishments and awareness that all individuals have different abilities); and safety and personal boundaries (establishing personal boundaries and respecting others' personal boundaries, differentiate safe and unsafe behaviors and situations).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yoga Based Psychotherapy Group

YBPG promotes self-regulation (attention span and physical and verbal expression/outbursts); self-soothing (breathing and movement techniques that physiologically calm when the child encounters stress or reminders of trauma); competency (successful social interaction, appropriate expression of needs and feelings, healthy coping with stress or crisis); self-awareness (of thoughts and feelings by first increasing awareness of the body and its sensations through yoga); self-esteem (positive self-regard, increase accomplishments and awareness that all individuals have different abilities); and safety and personal boundaries (establishing personal boundaries and respecting others' personal boundaries, differentiate safe and unsafe behaviors and situations).

Intervention Type BEHAVIORAL

Standard Mental Health Treatment

Trauma and evidence informed therapy

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

YBPG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children, ages 8-12 years,
* enrolled in treatment at KKFC and their caregivers will be invited to participate if the child continues to exhibit behavior dysregulation (Conners' Parent Rating Scale-Revised (S) of \> 60) following 3 months of SCMH at the KKFC.
* Children may have a history of receiving psychotropic medications or be currently taking stimulants at the time of study enrollment.

Exclusion Criteria

* Children who are on psychotropic medications or medications that affect their heart rates, other than stimulants will be excluded from this preliminary study.
* Children with cardiac arrhythmias, endocrine disorders associated with heart rate irregularities or who are not able to cooperate or understand study procedures will be excluded.
* Non-English speaking children will be excluded. Children in foster care placements will be excluded.
Minimum Eligible Age

8 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Substance Abuse and Mental Health Services Administration (SAMHSA)

FED

Sponsor Role collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Harolyn M.E.Belcher, M.D.

Director of Research, Family Center at Kennedy Krieger Institute

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Harolyn ME Belcher, MD

Role: PRINCIPAL_INVESTIGATOR

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kennedy Krieger Institute

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NA_00021817

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mindfulness-based Psilocybin Therapy for PTSD
NCT07104916 NOT_YET_RECRUITING PHASE2
Integrated Health Care for PTSD
NCT07220681 NOT_YET_RECRUITING NA
FamilyLive Feasibility and Effectiveness Study
NCT01524185 WITHDRAWN EARLY_PHASE1
Psilocybin-Assisted Randomized Therapy
NCT07332143 NOT_YET_RECRUITING PHASE2